Screener
Eligibility screening
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
2 US sites in MA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
2 US sites in MA
Before we begin
Your answer affects how the questions are phrased.